CONGRESS URGES THE FDA TO CHANGE GENRIC DRUG APPROVAL RULES

By: Kelda Doherty

Following the Supreme Court ruling in Mutual Pharmaceutical Co. v. Bartlett, which allowed generic manufactures to avoid state law liability for defectively designed drugs, members of congress have spoken out against this ruling. Congressional members and consumer groups renewed their plea for the FDA to change their generic drug approval rules in order to ensure that those consumers injured by generic drugs can seek redress through the courts. As it stands, generic drug manufactures cannot be sued by state law as it would conflict with federal law, however three senators and four representatives, all of whom were Democrats were of the opinion that this law needs revising.

Categories:

Don't Settle

for an Average Attorney
    • Please enter your name.
    • This isn't a valid phone number.
    • Please enter your email address.
      This isn't a valid email address.
    • Please make a selection.
    • Please enter a message.
Get RGRP On Your Side